Robert Burns
Stock Analyst at HC Wainwright & Co.
(2.94)
# 1,653
Out of 5,090 analysts
477
Total ratings
39.37%
Success rate
0.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NUVB Nuvation Bio | Reiterates: Buy | $10 | $8.55 | +16.96% | 16 | Dec 1, 2025 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $24 → $26 | $10.59 | +145.51% | 3 | Nov 20, 2025 | |
| ZYME Zymeworks | Maintains: Buy | $26 → $32 | $26.69 | +19.90% | 23 | Nov 18, 2025 | |
| ORIC ORIC Pharmaceuticals | Maintains: Buy | $19 → $23 | $11.00 | +109.09% | 26 | Nov 14, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $21 → $50 | $38.77 | +28.97% | 15 | Nov 13, 2025 | |
| BNTX BioNTech SE | Maintains: Buy | $136 → $140 | $96.25 | +45.45% | 46 | Nov 10, 2025 | |
| ACET Adicet Bio | Maintains: Buy | $4 → $9 | $0.53 | +1,584.76% | 2 | Nov 7, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $72 → $73 | $79.64 | -8.34% | 21 | Nov 6, 2025 | |
| EXEL Exelixis | Maintains: Buy | $46 → $49 | $44.36 | +10.46% | 11 | Nov 5, 2025 | |
| CRBU Caribou Biosciences | Maintains: Buy | $3 → $9 | $1.90 | +373.68% | 15 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $2 | $1.37 | +45.99% | 22 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.08 | +362.96% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3 | $2.22 | +35.44% | 19 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $28 | $18.09 | +54.78% | 19 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $10.61 | +13.10% | 20 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $7 | $5.42 | +29.15% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $3.29 | +112.77% | 22 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 | $5.75 | +160.87% | 3 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.40 | +316.67% | 5 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.46 | +242.47% | 17 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $13.69 | +97.22% | 1 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $5.56 | +43.88% | 9 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $20 | $9.85 | +103.05% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $3.06 | +1,011.11% | 4 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $7.68 | +82.29% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $18.20 | +119.78% | 5 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $42 | $24.69 | +70.11% | 11 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $2.67 | +274.53% | 14 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $10 | $2.11 | +373.93% | 3 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $8.00 | +62.50% | 8 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $21.81 | +120.08% | 5 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $1.94 | +518.56% | 3 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $9.63 | +34.99% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.19 | +320.17% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $1.43 | +459.44% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $14.33 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $16.27 | +1,129.26% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,320 → $240 | $1.46 | +16,338.36% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.61 | +24,514.37% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $3.95 | +178.48% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50,000 → $45,000 | $4.17 | +1,079,036.69% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $4.52 | +453.10% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.55 | +738.71% | 1 | Jan 7, 2021 |
Nuvation Bio
Dec 1, 2025
Reiterates: Buy
Price Target: $10
Current: $8.55
Upside: +16.96%
Cullinan Therapeutics
Nov 20, 2025
Maintains: Buy
Price Target: $24 → $26
Current: $10.59
Upside: +145.51%
Zymeworks
Nov 18, 2025
Maintains: Buy
Price Target: $26 → $32
Current: $26.69
Upside: +19.90%
ORIC Pharmaceuticals
Nov 14, 2025
Maintains: Buy
Price Target: $19 → $23
Current: $11.00
Upside: +109.09%
Cogent Biosciences
Nov 13, 2025
Maintains: Buy
Price Target: $21 → $50
Current: $38.77
Upside: +28.97%
BioNTech SE
Nov 10, 2025
Maintains: Buy
Price Target: $136 → $140
Current: $96.25
Upside: +45.45%
Adicet Bio
Nov 7, 2025
Maintains: Buy
Price Target: $4 → $9
Current: $0.53
Upside: +1,584.76%
Revolution Medicines
Nov 6, 2025
Maintains: Buy
Price Target: $72 → $73
Current: $79.64
Upside: -8.34%
Exelixis
Nov 5, 2025
Maintains: Buy
Price Target: $46 → $49
Current: $44.36
Upside: +10.46%
Caribou Biosciences
Nov 5, 2025
Maintains: Buy
Price Target: $3 → $9
Current: $1.90
Upside: +373.68%
Nov 3, 2025
Reiterates: Neutral
Price Target: $2
Current: $1.37
Upside: +45.99%
Oct 31, 2025
Upgrades: Buy
Price Target: $5
Current: $1.08
Upside: +362.96%
Oct 27, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $2.22
Upside: +35.44%
Oct 27, 2025
Maintains: Buy
Price Target: $33 → $28
Current: $18.09
Upside: +54.78%
Oct 27, 2025
Upgrades: Buy
Price Target: $12
Current: $10.61
Upside: +13.10%
Oct 20, 2025
Assumes: Buy
Price Target: $7
Current: $5.42
Upside: +29.15%
Oct 16, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.29
Upside: +112.77%
Oct 13, 2025
Upgrades: Buy
Price Target: $15
Current: $5.75
Upside: +160.87%
Oct 3, 2025
Reiterates: Buy
Price Target: $10
Current: $2.40
Upside: +316.67%
Sep 23, 2025
Reiterates: Buy
Price Target: $5
Current: $1.46
Upside: +242.47%
Sep 15, 2025
Initiates: Buy
Price Target: $27
Current: $13.69
Upside: +97.22%
Sep 12, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $5.56
Upside: +43.88%
Sep 10, 2025
Maintains: Buy
Price Target: $23 → $20
Current: $9.85
Upside: +103.05%
Aug 26, 2025
Reiterates: Buy
Price Target: $34
Current: $3.06
Upside: +1,011.11%
Aug 26, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $7.68
Upside: +82.29%
Aug 22, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $18.20
Upside: +119.78%
Aug 12, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $24.69
Upside: +70.11%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.67
Upside: +274.53%
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $2.11
Upside: +373.93%
Jul 17, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $8.00
Upside: +62.50%
Jul 2, 2025
Maintains: Buy
Price Target: $40 → $48
Current: $21.81
Upside: +120.08%
May 16, 2025
Reiterates: Buy
Price Target: $12
Current: $1.94
Upside: +518.56%
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $9.63
Upside: +34.99%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.19
Upside: +320.17%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.43
Upside: +459.44%
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $14.33
Upside: -
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $16.27
Upside: +1,129.26%
Mar 21, 2024
Maintains: Buy
Price Target: $1,320 → $240
Current: $1.46
Upside: +16,338.36%
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $0.61
Upside: +24,514.37%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $3.95
Upside: +178.48%
Nov 24, 2021
Maintains: Buy
Price Target: $50,000 → $45,000
Current: $4.17
Upside: +1,079,036.69%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $4.52
Upside: +453.10%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.55
Upside: +738.71%